Evidence map›Paper›PMID 42231429›Full record

ArticleMolecular horticulture2026

DIMORPH: an integrated multi-omics resource for camptothecin-producing plants.

Qian Lou, Xiangdong Pu, Wenjie Xu, Ranran Gao, Longlong Gao, Zhichao Xu, Zhe Wang, Xinyao Li, Tianyi Xin, Haitao Li and 7 more

Abstract read
In one paragraph

Article in Molecular horticulture, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Qian LouState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
Xiangdong PuAnhui Provincial Laboratory of Inflammatory and Immunity Disease, Anhui Institute of Innovative Drugs, School of Pharmacy, Hefei, 230032, China.
Wenjie XuState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
Ranran GaoKey Laboratory of Beijing for Identification and Safety Evaluation of Chinese Medicine, China Academy of Chinese Medical Sciences, Institute of Chinese Materia Medica, Beijing, 100700, China.
Longlong GaoState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
Zhichao XuCollege of Life Science, Northeast Forestry University, Harbin, 150040, China.
Zhe WangState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
Xinyao LiState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
Tianyi XinState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
Haitao LiYunnan Key Laboratory of Southern Medicinal Resources, Yunnan Branch Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Jinghong, 666100, China.
Wu WangYunnan Key Laboratory of Southern Medicinal Resources, Yunnan Branch Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Jinghong, 666100, China.
Deying TangYunnan Key Laboratory of Southern Medicinal Resources, Yunnan Branch Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Jinghong, 666100, China.
Anshun XuYunnan Key Laboratory of Southern Medicinal Resources, Yunnan Branch Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences, Jinghong, 666100, China.
Guihong QiState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
Yutong GanState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China.
Jinlan ZhangState Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.
Jingyuan SongState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, 100193, China. jysong@implad.ac.cn.ORCID http://orcid.org/0000-0001-7624-5459

Funding

Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Sciences 2021-I2M-1-029Yunnan Academician Expert Work station 202105AF150053
6 · The paper itself

Abstract

Over the past decade, extensive multi-omics data of camptothecin (CPT)-producing plants have been generated, resulting in a wealth of genomic resources. However, to date, no available database supports utilization for understanding biological mechanisms of CPT biosynthesis. In this study, we constructed DIMORPH ( https://www.dimorph.cn:9000 .), a Database Integrated Multiple Omics Resources for CPT-Producing Herbs. The database consolidated genomic, transcriptomic, and metabolic data of the three representative CPT-producing plants including Camptotheca acuminata, Ophiorrhiza pumila and Nothapodytes nimmoniana, and integrated functional annotation, synteny, and co-expression analytical results. Utilizing DIMORPH, a new CPT 10-hydroxylase (CPT10H), CYP81BQ24, was identified in C. acuminata. Structural comparison between CYP81BQ24 and CYP81BQ23 (CPT 11 hydroxylase), combined with fragment substitution mutagenesis, revealed ten key amino acid residues determined the regio-selectivity of CPT hydroxylases (CPTHs) at C-10 and C-11 position. Additionally, a high-efficiency CPT10H mutant was obtained through site-directed mutagenesis guided by sequence alignment and structural prediction of 17 CYP450 hydroxylases. Therefore, the comprehensive database focused on CPT will be helpful to the elucidation of CPT biosynthetic pathway and production of CPT-derived drugs.

Indexed as

CamptothecinCamptothecin hydroxylaseHigh-efficiency mutantOmics databaseRegio-selectivity

Identifiers

PMID42231429
PMCPMC13231748

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.